Lipopolysaccharide Receptors

"Lipopolysaccharide Receptors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

Glycolipid-anchored membrane glycoproteins expressed on cells of the myelomonocyte lineage including MONOCYTES; MACROPHAGES; and some GRANULOCYTES. They function as receptors for the complex of lipopolysaccharide (LPS) and LPS-binding protein.

Descriptor ID	D018950
MeSH Number(s)	D12.776.395.550.448.100 D12.776.543.484.500.100 D12.776.543.550.418.100 D12.776.543.750.705.045 D23.050.301.264.900.045 D23.101.100.900.045
Concept/Terms	Lipopolysaccharide Receptors Lipopolysaccharide Receptors Lipoglycan Receptor Receptor, Lipoglycan Receptors, Lipopolysaccharide CD14 Antigens Antigens, CD14 LPS Receptor Receptor, LPS CD14 Monocyte Differentiation Antigen CD14 Antigen

Below are MeSH descriptors whose meaning is more general than "Lipopolysaccharide Receptors".

Chemicals and Drugs [D]
Amino Acids, Peptides, and Proteins [D12]
Proteins [D12.776]
Glycoproteins [D12.776.395]
Membrane Glycoproteins [D12.776.395.550]
GPI-Linked Proteins [D12.776.395.550.448]
Lipopolysaccharide Receptors [D12.776.395.550.448.100]
Membrane Proteins [D12.776.543]
Lipid-Linked Proteins [D12.776.543.484]
GPI-Linked Proteins [D12.776.543.484.500]
Lipopolysaccharide Receptors [D12.776.543.484.500.100]
Membrane Glycoproteins [D12.776.543.550]
GPI-Linked Proteins [D12.776.543.550.418]
Lipopolysaccharide Receptors [D12.776.543.550.418.100]
Receptors, Cell Surface [D12.776.543.750]
Receptors, Immunologic [D12.776.543.750.705]
Lipopolysaccharide Receptors [D12.776.543.750.705.045]
Biological Factors [D23]
Antigens [D23.050]
Antigens, Surface [D23.050.301]
Antigens, Differentiation [D23.050.301.264]
Antigens, Differentiation, Myelomonocytic [D23.050.301.264.900]
Lipopolysaccharide Receptors [D23.050.301.264.900.045]
Biomarkers [D23.101]
Antigens, Differentiation [D23.101.100]
Antigens, Differentiation, Myelomonocytic [D23.101.100.900]
Lipopolysaccharide Receptors [D23.101.100.900.045]

Below are MeSH descriptors whose meaning is related to "Lipopolysaccharide Receptors".

Below are MeSH descriptors whose meaning is more specific than "Lipopolysaccharide Receptors".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Lipopolysaccharide Receptors" by people in this website by year, and whether "Lipopolysaccharide Receptors" was a major or minor topic of these publications.

Bar chart showing 18 publications over 15 distinct years, with a maximum of 3 publications in 2001

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1998	0	1	1
2001	0	3	3
2002	0	1	1
2003	0	1	1
2004	0	1	1
2007	0	1	1
2009	0	1	1
2011	1	0	1
2012	0	2	2
2013	1	0	1
2015	1	0	1
2018	1	0	1
2019	1	0	1
2022	1	0	1
2023	0	1	1

Below are the most recent publications written about "Lipopolysaccharide Receptors" by people in Profiles.

Sharygin D, Koniaris LG, Wells C, Zimmers TA, Hamidi T. Role of CD14 in human disease. Immunology. 2023 07; 169(3):260-270.

View in: PubMed
Chisari E, Cho J, Wouthuyzen-Bakker M, Parvizi J. Gut permeability may be associated with periprosthetic joint infection after total hip and knee arthroplasty. Sci Rep. 2022 09 05; 12(1):15094.

View in: PubMed
Roedig H, Damiescu R, Zeng-Brouwers J, Kutija I, Trebicka J, Wygrecka M, Schaefer L. Danger matrix molecules orchestrate CD14/CD44 signaling in cancer development. Semin Cancer Biol. 2020 05; 62:31-47.

View in: PubMed
Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LT, Brandts C, Fulda S, Wygrecka M, Schaefer L. Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol. 2019 04; 77:4-22.

View in: PubMed
Topcuoglu S, Arslanbuga C, Gursoy T, Aktas A, Karatekin G, Uluhan R, Ovali F. Role of presepsin in the diagnosis of late-onset neonatal sepsis in preterm infants. J Matern Fetal Neonatal Med. 2016; 29(11):1834-9.

View in: PubMed
Voss JG, Dobra A, Morse C, Kovacs JA, Danner RL, Munson PJ, Logan C, Rangel Z, Adelsberger JW, McLaughlin M, Adams LD, Raju R, Dalakas MC. Fatigue-related gene networks identified in CD(14)+ cells isolated from HIV-infected patients: part I: research findings. Biol Res Nurs. 2013 Apr; 15(2):137-51.

View in: PubMed
Janson C, Kasahara N, Prendergast GC, Colicelli J. RIN3 is a negative regulator of mast cell responses to SCF. PLoS One. 2012; 7(11):e49615.

View in: PubMed
Kotsakis A, Harasymczuk M, Schilling B, Georgoulias V, Argiris A, Whiteside TL. Myeloid-derived suppressor cell measurements in fresh and cryopreserved blood samples. J Immunol Methods. 2012 Jul 31; 381(1-2):14-22.

View in: PubMed
Voss JG, Dobra A, Morse C, Kovacs JA, Raju R, Danner RL, Munson PJ, Logan C, Rangel Z, Adelsberger JW, McLaughlin M, Adams LD, Dalakas MC. Fatigue-related gene networks identified in CD14+ cells isolated from HIV-infected patients: part II: statistical analysis. Biol Res Nurs. 2013 Apr; 15(2):152-9.

View in: PubMed
Patton JB, Rowland RR, Yoo D, Chang KO. Modulation of CD163 receptor expression and replication of porcine reproductive and respiratory syndrome virus in porcine macrophages. Virus Res. 2009 Mar; 140(1-2):161-71.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement